furosemide

Metabolite details

Identifier

ZZUFCTLCJUWOSV-UHFFFAOYSA-N

InChI Key

ZZUFCTLCJUWOSV-UHFFFAOYSA-N

IUPAC name

4-chloro-2-{[(furan-2-yl)methyl]amino}-5-sulfamoylbenzoic acid

Preferred name

furosemide

INN name

—

Synonym

2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid

ChEBI

CHEBI:47426

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Analysis of Growth Phases of Enterotoxigenic Escherichia coli Reveals a Distinct Transition Phase before Entry into Early Stationary Phase with Shifts in Tryptophan, Fucose, and Putrescine Metabolism and Degradation of Neurotransmitter Precursors
• Brain metabolomic profiling of eastern honey bee (Apis cerana) infested with the mite Varroa destructor.
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
• Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy

Observed in differential profiles

• E1777_Intracellular_MidLog_vs_E1777_Intracellular_EarlyStationary
• Mite_Infestation_vs_Control
• G1_Control_vs_G2_Arginine_Addition
• CIDP_patient_vs_healthy_control